NeuPath Health

NeuPath Health EBITDA Growth YoY

The Year-over-Year EBITDA Growth of NeuPath Health (NPTH.V) as of Nov 12, 2026 is -45.06 %. In the previous year, Year-over-Year EBITDA Growth was 19.61 % — a change of -329.80% (lower).

EBITDA Growth YoY

-45.06 %

YoY

-329.80%

Last updated:

Year-over-Year EBITDA Growth of NeuPath Health is 2025 -45.06 % . Year-over-Year EBITDA Growth of NeuPath Health was 2024 19.61 % . It decreases by -329.80% lower compared to the previous year.

The NeuPath Health EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2020
-6.20 CAD
Jan 1, 2021
-29.84 CAD
Jan 1, 2022
19.61 CAD
Jan 1, 2025
-45.06 CAD
The NeuPath Health EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-45.06 %-329.80%
19.61 %-165.72%
-29.84 %+381.19%
-6.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuPath Health stock

Year-over-Year EBITDA Growth of NeuPath Health is -45.06 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's NeuPath Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — NeuPath Health

All Key Metrics — NeuPath Health